Eli Lilly Q3 Profit Misses Estimates; Revenue Up 5%
Eli Lilly and Company (LLY) said it delivered solid financial results in the third quarter, as the company's key growth products continued to be the catalyst for volume-based revenue growth. On a non-GAAP basis, earnings per share increased 4 percent. Revenue rose 5 percent driven by volume growth of 9 percent. The company reaffirmed its earnings per share guidance for 2020 on a non-GAAP basis.
Source: RTTNews